.
Data from a variety of sources are provided to help human geneticists to assess and classify variants detected in their patients. MH Mendel includes population frequencies, reported clinical significance, and functional impact predictions for a plethora of variants. For analysis of germline variants associated with hereditary diseases, MH Mendel supports human geneticists in managing their own variant classifications and interpretations as well as in creating diagnostic reports.
"Genetic tests can reveal a predisposition to rare hereditary diseases. Today some hereditary diseases can be managed. Early detection and precise understanding is important to initiate treatment and to prevent avoidable irreparable defects. Results of genetic tests analyzed and evaluated by MH Mendel can reveal ae predisposition to diseases and help physicians to find the exact molecular cause and to create a personalized diagnostic report for each patient “, says Dr. Stephan Brock, CTO of Molecular Health. “We are glad that with MH Mendel we can now help patients and support physicians with our advanced and highly curated and integrated precision medicine technologies and expertise.”
- MH Mendel combines the most relevant information for the diagnosis of hereditary diseases
- MH Mendel helps patients and supports physicians through most modern and comprehensive precision medicine technologies and expertise
- MH Mendel becomes an integral part of IVD registered Molecular Health Guide® 3.0
Data from a variety of sources are provided to help human geneticists to assess and classify variants detected in their patients. MH Mendel includes population frequencies, reported clinical significance, and functional impact predictions for a plethora of variants. For analysis of germline variants associated with hereditary diseases, MH Mendel supports human geneticists in managing their own variant classifications and interpretations as well as in creating diagnostic reports.
"Genetic tests can reveal a predisposition to rare hereditary diseases. Today some hereditary diseases can be managed. Early detection and precise understanding is important to initiate treatment and to prevent avoidable irreparable defects. Results of genetic tests analyzed and evaluated by MH Mendel can reveal ae predisposition to diseases and help physicians to find the exact molecular cause and to create a personalized diagnostic report for each patient “, says Dr. Stephan Brock, CTO of Molecular Health. “We are glad that with MH Mendel we can now help patients and support physicians with our advanced and highly curated and integrated precision medicine technologies and expertise.”
